Human Reproduction, Vol. 18, No. 10, 2166-2168,
October 2003
© 2003 European Society of Human Reproduction and Embryology
An in-vitro study of ginsenoside Rb1-induced teratogenicity using a whole rat embryo culture model
Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
1 To whom correspondence should be addressed. e-mail: lyschan{at}cuhk.edu.hk
BACKGROUND: Ginseng is a commonly used herbal medicine worldwide. However, there is limited information regarding its effects on the developing embryo. METHODS: The effect of ginsenoside on the developing embryo during the critical period of organogenesis was investigated using a whole rat embryo culture model. Embryos were exposed to various concentrations of ginsenoside Rb1 and scored for growth and differentiation at the end of the culture period. RESULTS: Median total morphological scores in embryos exposed to 30 µg/ml of ginsenoside Rb1 was significantly lower (P < 0.05) than that in control embryos (35 versus 45). Morphological scores for flexion, forelimb and hindlimb were also significantly reduced. The median total morphological scores further decreased to 28 when the concentration of ginsenoside Rb1 was increased to 50 µg/ml. At this concentration, the embryonic crownrump length and somite number were also significantly reduced compared with control embryos (2.8 versus 3.0 mm and 16.0 versus 21.0, respectively). CONCLUSIONS: Our study has demonstrated that ginsenoside exerts direct teratogenic effects on rat embryos. Until more is known about the effects of ginsenoside in women of reproductive age, we suggest its use should be treated with caution.
Key words: ginseng/ginsenoside Rb1/teratogenicity/whole rat embryo culture
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Cho, W. Park, S. Lee, W. Ahn, and Y. Lee Ginsenoside-Rb1 from Panax ginseng C.A. Meyer Activates Estrogen Receptor-{alpha} and -{beta}, Independent of Ligand Binding J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3510 - 3515. [Abstract] [Full Text] [PDF] |
||||
